AlphaYouAB
Schedule 13G filing
ACORN BIOVENTURES, L.P. disclosed a 5.7% stake in Karyopharm Therapeutics Inc. (KPTI)
ACORN BIOVENTURES, L.P. reported owning 5.7% of Karyopharm Therapeutics Inc. (KPTI) (1,284,221 shares) in a Schedule 13G filed Sep 25, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Sep 25, 2026
- Source
- Schedule 13G
More KPTI insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.